Objectives: Despite increased hospice use over the last decade, end-of-life care intensity continues to increase. To understand this puzzle, we sought to examine regional variation in intensive end-oflife care and determine its associations with hospice use patterns.
F or decades, research has documented extensive Medicare spending for beneficiaries in their last year of life. 1 Approximately 5% of Medicare enrollees who died in a chosen calendar year accounted for 25.1% of total Medicare annual spending. 2 More than 70% of all terminal-year expenses occurred during the last 6 months of life. 3, 4 Furthermore, such intensity of care is not always aligned with patient and family preferences [5] [6] [7] and is not associated with better quality of care. 8 Hospice programs have expanded markedly in recent decades. 9, 10 Previous research demonstrated that rising trends in hospice use corresponded with a decreased likelihood of dying in the hospital 11, 12 ; however, the intensity of care at the end of life is still increasing. 11, 12 To explain this puzzling finding, researchers have speculated that hospice use may be an "add-on" to a growing pattern of more utilization of intensive end-of-life care, after finding that there has also been a recent increase in the number of short hospice stays after a hospitalization. 11 Yet previous studies have not empirically examined whether areas with higher rates of more intensive end-of-life care also have higher rates of very short hospice enrollments. The issue of appropriate timing of hospice referral is of great interest 13 : for instance, very short hospice enrollment (ie, within 7 d of death) has been proposed as a measure of poor quality of end-of-life care, 14 as short length of hospice enrollment has been linked to fewer hospice services received, increased unmet need, and clinical depression among family members. 15, 16 Evidence of strong correlation between end-of-life care intensity and hospice use (no hospice vs. any hospice), as well as length of hospice use (very short, medium, and very long), may help explain the persistent trends of increasing end-of-life care intensity while hospice use is also expanding nationally. As hospice use has been embraced as the end-of-life care standard, it is imperative to know about how end-of-life care intensity relates to hospice use patterns. Accordingly, we sought to examine the association between intensity of care in the last 6 months of life and hospice use patterns. We take advantage of regional-level variation in patterns of end-of-life care using data from Medicare fee-for-service decedents. We examined not only overall hospice use but also the length of hospice use, with the hypothesis that an increase in intensity of care in the last 6 months of life may be associated with increased very short hospice use. Findings from this study may provide a more nuanced view of hospice use, recognizing that increases in some types of hospice use (ie, short-duration) may paradoxically co-occur with increases in intensity of care at the end of life.
METHODS

Study Design and Sample
We conducted a retrospective analysis of all inpatient care and hospice fee-for-service Medicare claims in the 6 months before death among all decedents older than 66 years who died between July 1, 2011 and December 31, 2011. We limited our sample to beneficiaries who were enrolled in Medicare Parts A and B 6 months before death. We conducted hospital referral region (HRR)-level analyses so that we could have sufficient sample size (number of HRR = 306) and adequate number of decedents in each HRR. The study was reviewed by the Institutional Review Board of Yale University and was exempt from full review.
Measurement
End-of-Life Care Intensity
The measures of end-of-life care intensity were chosen on the basis of previous literature and data availability. [17] [18] [19] We included the HRR-level percentage of patients having any hospitalizations, the percentage of patients having any hospitalizations through emergency department (ED) visits, the percentage of patients having any intensive care unit (ICU) admissions, the number of days spent in hospital (hospital-days), and the number of days spent in ICUs (ICUdays). Hospitalization represented a composite measure as it encompasses hospitalization through ED use, and ICU admission. To ascertain these data, we used any revenue center code values of 0450-0459 (emergency room) and 0981 (professional fees-emergency room) in the Medicare claims to capture ED visits. Any revenue center code values of 0200-0219 (excluding 0204, 0205, and 0215) in the inpatient claims were used to determine ICU admission. Given the nature of regional-level analyses, we calculated the proportion of decedents who used intensive care in each HRR and the mean number of days spent in hospital or ICU in each HRR. For each intensive end-of-life care, we assigned the HRRs to 5 quintiles, where quintile 1 represents HRRs with the lowest end-of-life care intensity and quintile 5 represents those with the highest end-of-life care intensity.
Hospice Use
We created a set of binary variables to indicate use of hospice, as well as lengths of hospice use. For the decedents who enrolled with a hospice, we created 3 binary measures to indicate the following: the decedent experienced very short hospice enrollment (enrollment of r7 d), medium-length hospice enrollment (enrollment between 8 and 179 d), or very long hospice enrollment (enrollment of Z180 d). Very short hospice enrollment indicated hospice use for r7 days of enrollment and that the last hospice enrollment had been initiated r7 days before death. 20
Covariates
We included as candidate covariates patient age (categorized as 66-69, 70-74, 75-79, 80-84, and Z85 y), sex, and race/ethnicity (non-Hispanic white, black, Hispanic, and other). We ascertained chronic conditions using data from the Master Beneficiary Summary File, including heart disease (acute myocardial infarction, heart failure, and ischemic heart disease), Alzheimer disease or dementia, kidney disease, diabetes, chronic obstructive pulmonary disease or asthma, depression, stroke, and cancer (breast, colorectal, prostate, lung, and endometrial). In addition, we used zip code information to identify the county of residence and the HRR for each beneficiary. We then used data pertaining to the county in which the patient resided using the Area Resource File, which included median county-level income and the percentage of adults in the county with a high-school education or less; the percentage of individuals in health maintenance organizations in the county; and the number of physicians, hospital beds, skilled nursing facility beds, hospices, and home health agencies per 1000 people aged 65 years and above in the county.
Statistical Analysis
Analyses were performed separately on the basis of overall hospice use, very short hospice use, medium-length hospice use, and very long hospice use. We calculated intensive end-of-life care measures, for the total sample and for strata defined by the type of hospice use (no hospice, any hospice, very short, medium, and very long hospice enrollments). We compared intensive end-of-life care measures between decedents who did not use hospice and the other groups, using w 2 test for proportion measures and paired t test for continuous measures.
In the HRR-level analyses, we calculated the proportions of decedents in each HRR who received intensive end-of-life care as we defined above during the study period, as well as the average length of stay in hospital or ICU in each HRR. We also determined the proportion of decedents who used hospice in each HRR and the proportion of hospice users with very short hospice use, medium-length hospice use, and very long hospice use. Correlations between hospital-based service utilization and hospice-use patterns across HRR-level measures were tested using the Pearson correlation coefficient.
In the adjusted analyses, we used 2-level hierarchical generalized linear models to examine the HRR-level associations between end-of-life care intensity and hospice use patterns. We included an HRR-level covariate according to the proportion of decedents who used any intensive end-oflife care (categorized by quintile) in multivariable analyses. Our hierarchical generalized linear models allowed us to estimate the associations between end-of-life care intensity and hospice use pattern at the HRR level while simultaneously adjusting for patient characteristics and market factors and accounting for the structure that patients were clustered within HRRs. Using each hospice use pattern as the dependent variable, we evaluated risk estimates across quintiles. For analyses of overall hospice use, all decedents were included. Analyses of length of hospice use were limited to hospice users. All statistical analyses were completed using SAS version 9.3 (SAS Institute, Cary, NC). To account for multiple comparisons in our study, we applied a Bonferroni correction; thus, a 2-tailed P < 0.01 was used to define statistical significance. We reported adjusted odds ratios (AORs) with 99% confidence intervals (CIs).
RESULTS
Patient Characteristics
The full study sample consisted of 660,132 decedents enrolled in fee-for-service Medicare during the last 6 months of life. Characteristics of decedents are summarized in Table 1 . Approximately 45% of decedents were 85 years or above, 55% were women, and the majority were white. Most had chronic conditions such as heart disease (75.4%), chronic lung disease (48.1%), and diabetes (44.3%).
A total of 348,519 (52.8%) decedents did not use hospice in the last 6 months of life; 68.4% of them had been hospitalized with mean hospital-days of 12.3 days ( Table 2) . Compared with decedents who did not use hospice, hospice users were less likely to be hospitalized (66.1%, P < 0.001). Among those hospice users, 32.4% had very short hospice enrollments, and they were significantly more likely to experience hospitalization than decedents who did not use hospice (83.5%, P < 0.001); 57.6% had medium-length hospice use, and they were less likely than decedents without hospice use to incur intensive end-of-life care (P < 0.001 for all measures); and decedents with very long hospice enrollments were significantly less likely to receive intensive end-of-life care with hospitalization rate of 8.3% in the last 6 months of life (P < 0.001).
Regional-level End-of-Life Care Intensity
The average proportion of decedents in an HRR who had at least 1 hospitalization in the last 6 months of life was 66.4% (SD = 5.5%), ranging from 48.6% to 81.9% (Fig. 1A) . The average percentage of hospitalization through ED visits in the last 6 months was 55.8% (SD = 9.1%, from 26.1% to 75.4%); the percentage of ICU admissions in the last 6 months was 35.5% (SD = 8.5%, from 15.4% to 66.4%); the average number of days spent in hospital in the last 6 months was 10.6 days (SD = 2.9, from 4.3 to 21.9 d); and the average number of ICU-days was 2.8 days (SD = 1.2, from 0.7 to 8.6 d). Overall hospice use among decedents and hospice use patterns among hospice users also varied substantially across HRRs (Fig. 1B) .
HRR-level Intensity of End-of-Life Care and Hospice-Use Patterns
In unadjusted analyses, all measures of HRR-level end-oflife care intensity were significantly associated with increased proportions of decedents having very short hospice enrollment (Table 3 ). End-of-life care intensity was also significantly negatively correlated with the proportions of hospice users who had medium-length hospice enrollment. At the HRR-level, none of the measures of care intensity was significantly correlated with the overall proportion of decedents who used hospice, except a positive correlation between ICU admission and the proportion having used hospice at all.
HRRs in the highest compared with the lowest quintile of hospitalization did not significantly differ in rates of overall hospice use with AOR of 1.05 (99% CI, 0.89-1.25); but had significantly elevated rates of very short hospice use with AOR of 1.14 (99% CI, 1.04-1.25; Table 4 ). For nearly all other measures of intensive end-of-life care, HRRs in the highest compared with lowest quintile of end-of-life care intensity had significantly higher rates of very short hospice use: AOR, 1.23 (99% CI, 1.12-1.36) for hospitalization through ED use; AOR, 1.25 (99% CI, 1.14-1.38) for ICU admission; and AOR, 1.20 (99% CI, 1.08-1.32) for ICU-days. The exception to this is hospital-days marginally significant with AOR, 1.10 (99% CI, 1.00-1.21). HRRs with increased intensive end-of-life care also had significantly lower rates of hospice users with medium-length enrollments. Most of the associations between end-of-life care intensity and very long hospice use were statistically insignificant.
DISCUSSION
We found that approximately two thirds of Medicare beneficiaries who died in 2011 used hospital, ED, or ICU services in the last 6 months of life, a proportion that varied substantially across HRRs nationally. In addition, of the decedents who enrolled in hospice, 32% of hospice users had very short enrollments, versus 58% with medium-length and 10% with very long enrollments. Notably, HRRs with greater intensity of end-of-life care also had significantly higher proportions of decedents with very short hospice enrollments before death. These associations remained statistically significant after adjusting for individual patient characteristics and regional health care supply factors. Previous data have documented substantial increases in hospice use, short hospice enrollments, and ICU admissions during the last 6 months of life. 11 Our results help resolve the puzzle of increasing end-of-life care intensity while at the same time having increased hospice use by demonstrating that certain patterns of hospice use are linked to higher end-of-life care intensity. The finding supports the idea that much of the increases in hospice, especially the 30% of very short hospice use, may be as an "add-on" to an otherwise high-intensity course of care. 11 Our findings are important for policy decision making, especially in regions with high end-of-life care intensity. Efforts that aim only at increasing the number of individuals who access hospice, without paying attention to factors that influence the timeliness of hospice enrollment, may miss opportunities to leverage the benefits of hospice care in mitigating high end-of-life care intensity.
The differences in end-of-life care intensity among groups experiencing different lengths of hospice enrollment are particularly intriguing. Although decedents who used hospice were significantly less likely to use intensive end-of-life care, the differences were not substantial except with regard to the measures of ICU use. In our study, more than four fifths of very short hospice users were hospitalized, approximately three fourths had an ED visit, and one half had an ICU admission-all of which are proportions demonstrating that very short hospice users experienced more intensive care than that experienced by nonhospice users. In fact, nonhospice users and very short hospice users experienced more intensive endof-life care than medium or very long hospice users did. These findings suggest that nonhospice users and users of very short hospice may have important factors in common (eg, absences in end-of-life planning), which could in turn drive both more intensive care and difficulty in timing hospice enrollment. In contrast, minimal proportions of very long hospice users incurred intensive care in the last 6 months. Although these patients would have increased spending on hospice services, very long hospice use may decrease patient's suffering where end-of-life care intensity is concerned. Nonetheless, our results underscore the necessity to identify and address regional factors that may be affecting both timely hospice enrollment and intensity of end-of-life care.
The existing literature is mixed on whether hospice use serves as a complement to or a substitution for hospital-based services at the end of life. 2 Wennberg et al 19 have found that hospice use was inversely correlated with hospital stays in the last 6 months of life, suggesting substitution effects between hospice and hospital care; however, increased numbers of very short hospice enrollments after a hospitalization has suggested that hospice and hospital-based care may be complements, 11 a suggestion that is consistent with the data that end-of-life care in the United States remains highly intensive, even as hospice use has dramatically expanded in recent decades. 12, 21 Our results imply that both complementary and substitutional effects may exist. For some beneficiaries, timely hospice use may decrease hospitalbased services, whereas for others, hospice use may be used as an "add-on" to conventional hospital-based services. Previous literature has shown that the intensity of health care at the end of life varies widely across the United States. 8 There is a growing concern about regional variation in end-of-life care intensity as high-intensity care seems misaligned with patient preferences and may represent inefficient or poor-quality care. 21 The Dartmouth Atlas of Health Care, for instance, has reported the intensity of hospital resource utilization. 21 Our measures differ from the Dartmouth measures because we included all decedents irrespective of hospitalization status and conditions, whereas the cohort in the Dartmouth Atlas is restricted to beneficiaries with at least 1 hospital admission for 1 of 11 diagnoses that were known to confer a high-risk inpatient mortality. 22 Building upon previous research, our study provided a more comprehensive picture on geographic variation of care intensity at the end of life in the United States.
Our findings should be interpreted in light of several limitations. First, our focus was on associations between endof-life care intensity and hospice use pattern across HRRs, which was different from individual-level analyses. For example, researchers found that the growth in hospice care for nursing home residents was associated with less aggressive care near death. 23 However, our findings are informative to policy makers and may facilitate their efforts on monitoring, benchmarking, and improving end-of-life care quality at the population level. Second, although our model adjusted for chronic conditions, we did not know the severity of disease, nor did we have information on patient preference of hospice use and end-of-life care. Nonetheless, previous literature has shown that patient preferences explain little of regional variation in end-of-life health care utilization. 7 Third, we did not have complete cost information and thus could not include cost in our measures. Future research is needed. Finally, as a cross-sectional study, our research cannot be interpreted to make causal inferences. Future research using longitudinal data and econometric models is needed.
In conclusion, we provided contemporary data on regional-level variation in end-of-life care intensity, as well as its associations with overall hospice use and lengths of hospice use. Our study demonstrated that, at the regional level, associations between end-of-life care intensity and overall hospice use were not straightforward. In contrast, increased end-of-life care intensity was consistently associated with very short hospice use. Effective efforts to reduce hospitalization and intensive care at the end of life would benefit from focusing not only on the use of hospice, but also on earlier introduction of hospice in the course of care. .37 (1.15-1.65)  1.25 (1.14-1.38 
